Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 8409

Sort by

Sort Order Select

Journal Articles

Impact of Quality and Type of Anticoagulant Treatment, and Inflammatory Biomarkers on Quality of Life and Psychological Morbidity in Patients with Atrial Fibrillation: An Exploratory Study

ANA MONICA Machado, Fernanda Leite Msc Phd, M.Graça Pereira

Blood (2023) 142 (Supplement 1): 7302.

https://doi.org/10.1182/blood-2023-178127

Published: 2023

Journal Articles

Quality of Oral Anticoagulation with Vitamin K Antagonists and Direct Oral Anticoagulants in ‘real-World’ Patients: Lessons from a Five Years Audit Study

Fernanda Leite Msc Phd, Sara Almeida Ferreira, Ângela Leite

Blood (2023) 142 (Supplement 1): 5551.

https://doi.org/10.1182/blood-2023-188834

Published: 2023

Journal Articles

Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms

Nicholas Williams, PhD, Joe Lee, MBBS, Luiza Moore, PhD, Joanna E Baxter, PhD, James Hewinson, PhD, Kevin J Dawson, PhD, Andrew Menzies, MSc, Anna L Godfrey, PhD, Anthony R Green, PhDFRCPath FMedSci, Peter J Campbell, PhD, Jyoti Nangalia, MBBChir

Blood (2020) 136 (Supplement_2): LBA-1.

https://doi.org/10.1182/blood-2020-143813

Published: 2020

Journal Articles

A Multicentre Randomised Trial of First Line Treatment Pathways for Newly Diagnosed Immune Thrombocytopenia: Standard Steroid Treatment Versus Combined Steroid and Mycophenolate. the Flight Trial

Charlotte A Bradbury, MD MSc, FRCP, FRCPath, PhD, Rosemary Greenwood, Julie Pell, Katie Breheny, Rebecca Kandiyali, Jenny Ingram, Ian Thomas, Catherine Bagot, MD FRCPath, MBBS, Quentin Hill, HaemSTAR Collaborators, Nichola Cooper

Blood (2020) 136 (Supplement_2): LBA-2.

https://doi.org/10.1182/blood-2020-143563

Published: 2020

Journal Articles

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies

Steven W. Pipe, MD, Michael Recht, MD PhD, Nigel S. Key, MD, Frank W.G. Leebeek, MD PhD, Giancarlo Castaman, MD, Susan U. Lattimore, R.N., Paul Van Der Valk, Kathelijne Peerlinck, MD PhD, Michiel Coppens, MD, Niamh O'Connell, MD PhD, John Pasi, MB, ChB, PhD FRCP, FRCPath, FRCPCH, Peter Kampmann, MD, Karina Meijer, MD PhD, Annette von Drygalski, MD Pharm D, Guy Young, MD, Cedric Hermans, MDMRCP,PhD, Jan Astermark, MD PhD, Robert Klamroth, MD PhD, Richard S. Lemons, MD, Nathan Visweshwar, MD, Shelley Crary, MD MS, Rashid Kazmi, MBBS, Emily Symington, Miguel A. Escobar, MD, Esteban Gomez, MD, Rebecca Kruse-Jarres, MD, Adam Kotowski, MD, Doris Quon, MD PhD, Michael Wang, MD, Allison P. Wheeler, MD, Eileen K Sawyer, PhD, Stephanie Verweij, BSc, Valerie Colletta, MSc, Naghmana Bajma, MD, Robert Gut, MD PhD, Wolfgang A. Miesbach, MD PhD

Blood (2020) 136 (Supplement_2): LBA-6.

https://doi.org/10.1182/blood-2020-143560

Published: 2020

Journal Articles

MRD Xenotransplantation Prospectively Identifies Treatment-Selected Acute Lymphoblastic Leukemia Subpopulations with Relapse-Initiating Potential

Nina Rolf, MDPhD, Angela Tsang, Lorraine Liu, Amanda Lorentzian, BSc, Pascal Leclair, MSc, Annette Patterson, PhD, Philipp Lange, PhD, Christopher Maxwell, PhD, Chinten J. Lim, PhD, Ramon Klein Geltink, PhD, Suzanne M. Vercauteren, MD PhD FRCPC, Gregor S. D. Reid, PhD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-143408

Published: 2020

Journal Articles

Integrative DNA Methylation and Gene Expression Analysis Reveals Candidate Biomarkers Associated with Dichotomized Response to Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma

Ellen K. Kendall, BA, Manishkumar S. Patel, PhDMS,BPharm, Sarah Ondrejka, DO, Agrima Mian, MBBS, MD, Yazeed Sawalha, MD, Bo Hu, PhD, Eric D. Hsi, MD, Brian T. Hill, MD, Neetu Gupta, PhD MSc, BSc

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-137180

Published: 2020

Journal Articles

TRAF3 Loss Drives Alternative NF-κB Pathway Activation in Diffuse Large B-Cell Lymphoma

Michael Y. Li, BS, Lauren C. Chong, MSc, Elizabeth Chavez, BSc, Cg RT, Bruce W Woolcock, Adele Telenius, Vivian Lam, Gerald Krystal, PhD, David W. Scott, MBChB, PhD, Elena Viganò, PhD, Shannon Healy, PhD, Christian Steidl, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141126

Published: 2020

Journal Articles

"Detection of BCR-ABL1 -like Subtype in Adult Acute Lymphoblastic Leukemia Using Digital Ncounter Nanostring Technology"

Dikshat Gopal Gupta, MSc, Neelam Varma, MD, Shano Naseem, MD, Man Updesh Singh Sachdeva, MD, Pankaj Malhotra, MD, Sreejesh Sreedharanunni, DM, Subhash Varma, MD, Parveen Bose, MSc, Minakshi Gupta, MSc, Palak Rana, BSc, Yogeshwar Binota, Msc, Preeti Sonam, BSc

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-136890

Published: 2020

Journal Articles

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Justine M. Kahn, MDMSc, Kara M. Kelly, MD, Qinglin Pei, PhD, Yue Wu, MS, Debra L. Friedman, MD, Tara O. Henderson, MD MPH, David C. Hodgson, MD MPH, FRCPC, Joel A. Kaplan, DO, MPH, Frank G. Keller, MD, Smita Bhatia, MDMPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138796

Published: 2020

Journal Articles

Studying Immunophenotypic Modulation at Different Time Points of Chemotherapy : A Walk through the Disease Course in 121 Pediatric B Lymphoblastic Leukemia Cases; Providing Implications for MRD Detection

Omer Javed, FCPS , DipRCPath, Neelum Mansoor, MBBS , FCPS, Hamza Khan, MBBS, Naeem Jabbar, FCPS, Talha Israr, MSc, Saba Jamal, MBBS, Diplomate American Board of Anatomic and Clinical Pathology, Diplomate American Board of Hematology, Fatima Meraj, MBBS, FCPS

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-140213

Published: 2020

Journal Articles

CPX351 Has Short Remission Duration but Is an Effective Bridge to Allogeneic Transplant in High Risk AML: Results from Canadian Real-World Multi-Centre Study

Claire Andrews, Taylor Young, Eshetu G Atenafu, M.Sc., P.Stat, Sarit E Assouline, MD MSc, Joseph M Brandwein, MD, Steven M Chan, MD PhD, Signy Chow, MD FRCP(C), Dina Khalaf, BSc, MSc, MD, Vikas Gupta, MD FRCP, FRCPath, Dennis Dong Hwan Kim, MD, Dawn Maze, MDFRCPC,MSc, Mark D. Minden, Caroline J McNamara, MBBS, Tracy Murphy, MDFRCP,FRCPath, David Sanford, MD, Aaron D Schimmer, MD PhD, Andre C. Schuh, Karen W.L. Yee, MD, Hassan Sibai, MBBS

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-142990

Published: 2020

Journal Articles

Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-138943

Published: 2020

Journal Articles

R-CHOP Versus R-Bendamustine with or without Rituximab Maintenance in Newly Diagnosed Follicular Lymphoma Patients with High SUV at Baseline PET

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-136438

Published: 2020

Journal Articles

Global Transcriptional States of Follicular Lymphoma B Cells Highlight Distinct Groups of Tumor Identity Associated with Somatic Alterations and Tumor Microenvironment

Jordan Krull, BS, Kerstin Wenzl, PhD, Michelle Manske, MS, BS, Melissa Hopper, MSc, Melissa C. Larson, MS, Vivekananda Sarangi, Matthew J. Maurer, MS, Zhi-Zhang Yang, PhD, Lisa M. Rimsza, MD, Brian K. Link, MD, Thomas M. Habermann, MD, Stephen M. Ansell, MD PhD, Rebecca L. King, MD, James R. Cerhan, MD PhD, Anne J. Novak, PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-142744

Published: 2020

Journal Articles

A Longitudinal Population Level Analysis of Healthcare Resource Utilization, Comorbidity, and Survival in Idiopathic Multicentric Castleman Disease Patients

Sudipto Mukherjee, MD PhD MPH, Rabecka Martin, PhD, Brenda Sande, Chad Glen, PhD, Jeremy Paige, MDPhD, Suresh Yarlagadda, MD MPH, David C Fajgenbaum, MDMBA,MSc

Blood (2020) 136 (Supplement 1): 11.

https://doi.org/10.1182/blood-2020-140449

Published: 2020

Journal Articles

Shifting Treatment Patterns and Clinical Outcomes in Veterans Diagnosed with Waldenstrom Macroglobulinemia from 2006 to 2018

Hsu-Chih Chien, PhD MSc, Deborah Kay Morreall, BS, Vikas Patil, MS, Kelli M Rasmussen, BSc,MS, Christina Yong, MA, Catherine Li, PhD, Zachary R Burningham, PhD, Brian C Sauer, PhD, Ahmad S Halwani, MD PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-141427

Published: 2020

Journal Articles

Patient Characteristics of Long-Term Responders to Mogamulizumab: Results from the MAVORIC Study

Youn H. Kim, MD, Michael S. Khodadoust, MD PhD, Adele de Masson, MD PhD, Hélène Moins-Teisserenc, Takahiro Ito, MSc, Karen Dwyer, BA, Fiona Herr, PhD, Martine Bagot, MD PhD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-141379

Published: 2020

Journal Articles

GATA3 Gene - a Potential New Biomarker Associated with Adverse Outcomes in ALK1-Negative Anaplastic Large Cell Lymphoma: Preliminary Results from a Retrospective Cohort of 80 South American Cases of Nodal Peripheral T Lymphoma

Luis Alberto de Padua Covas Lage, MD PhD, Claudio Vinicius Brito, MD, Debora Levy, MSc, PhD, Hebert Fabricio Culler, MSc, PhD, Samuel Campanelli Freitas Couto, PhD, Lucas BO Alves, PhD, Maria C Zerbini, MD PhD Prof MD, Vanderson Rocha, MD PhD, Juliana Pereira, MD PhD

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-140833

Published: 2020

Journal Articles

A Novel Therapeutic DNA Vaccine Elicits Reduction of Tumor Clones and Favorable Perturbations in the Immune Microenvironment in Patients (pts) with Untreated Smoldering Waldenström Macroglobulinemia (sWM)

Sheeba K. Thomas, MD, Soung-chul Cha, PhD, Sapna R Parshottam, MSc, Sheetal S. Rao, PhD, Jasper B. Olsem, B.S.N., Brandon N. Crumpton, Szymon Szymura, PhD, Zhe Wang, PhD, Aaron Anderson, Lei Feng, MS, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Sattva S. Neelapu, MD, Larry W Kwak, MD PhD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-140007

Published: 2020

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Impact of Quality and Type of Anticoagulant Treatment, and Inflammatory Biomarkers on Quality of Life and Psychological Morbidity in Patients with Atrial Fibrillation: An Exploratory Study

Quality of Oral Anticoagulation with Vitamin K Antagonists and Direct Oral Anticoagulants in ‘real-World’ Patients: Lessons from a Five Years Audit Study

Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms

A Multicentre Randomised Trial of First Line Treatment Pathways for Newly Diagnosed Immune Thrombocytopenia: Standard Steroid Treatment Versus Combined Steroid and Mycophenolate. the Flight Trial

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies

MRD Xenotransplantation Prospectively Identifies Treatment-Selected Acute Lymphoblastic Leukemia Subpopulations with Relapse-Initiating Potential

Integrative DNA Methylation and Gene Expression Analysis Reveals Candidate Biomarkers Associated with Dichotomized Response to Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma

TRAF3 Loss Drives Alternative NF-κB Pathway Activation in Diffuse Large B-Cell Lymphoma

"Detection of BCR-ABL1 -like Subtype in Adult Acute Lymphoblastic Leukemia Using Digital Ncounter Nanostring Technology"

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Studying Immunophenotypic Modulation at Different Time Points of Chemotherapy : A Walk through the Disease Course in 121 Pediatric B Lymphoblastic Leukemia Cases; Providing Implications for MRD Detection

CPX351 Has Short Remission Duration but Is an Effective Bridge to Allogeneic Transplant in High Risk AML: Results from Canadian Real-World Multi-Centre Study

Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA

R-CHOP Versus R-Bendamustine with or without Rituximab Maintenance in Newly Diagnosed Follicular Lymphoma Patients with High SUV at Baseline PET

Global Transcriptional States of Follicular Lymphoma B Cells Highlight Distinct Groups of Tumor Identity Associated with Somatic Alterations and Tumor Microenvironment

A Longitudinal Population Level Analysis of Healthcare Resource Utilization, Comorbidity, and Survival in Idiopathic Multicentric Castleman Disease Patients

Shifting Treatment Patterns and Clinical Outcomes in Veterans Diagnosed with Waldenstrom Macroglobulinemia from 2006 to 2018

Patient Characteristics of Long-Term Responders to Mogamulizumab: Results from the MAVORIC Study

GATA3 Gene - a Potential New Biomarker Associated with Adverse Outcomes in ALK1-Negative Anaplastic Large Cell Lymphoma: Preliminary Results from a Retrospective Cohort of 80 South American Cases of Nodal Peripheral T Lymphoma

A Novel Therapeutic DNA Vaccine Elicits Reduction of Tumor Clones and Favorable Perturbations in the Immune Microenvironment in Patients (pts) with Untreated Smoldering Waldenström Macroglobulinemia (sWM)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only